Globus Medical Inc <GMED.N>: UBS Initiates Coverage With Neutral Rating; Target Price $82
GMED•Related News
US shares of JD.com fall after Q2 revenue decline
JD•
Lifeway Foods slumps as higher costs dent Q2 profit
LWAY•
Nyse Halt PSQ Holdings Wnt <PSQH_t.N> News Pending Lst $0.029500
PSQH•
Silence Therapeutics 10% owner Richard Ian Griffiths disposes of ADS worth $87.88 million
SLN•
Nasdaq trade halt <OBX.O> volatility trading pause at 10:33 AM
OBX•